NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Gene Therapy


Return to Library

Free Gene Therapy Articles


Study findings from University of Connecticut broaden understanding of antisense technology



2009 AUG 3 - (NewsRx.com) -- According to a study from the United States, "We show here that expression of genes from convergent transcription units can be regulated by the formation of double-stranded RNA ( dsRNA) in the region of overlapping polyadenylation signals. The model system employed is the mouse polyomavirus."

"The early and late genes of polyomavirus are transcribed from opposite strands of the circular viral genome. At early times after infection, the early genes are expressed predominantly. Late gene expression increases dramatically upon the onset of DNA replication, when a major defect in polyadenylation of the late primary transcripts generates multigenomic RNAs that are precursors to the mature late mRNAs. Embedded in these late pre-mRNAs are sequences complementary to the early RNAs that act to down-regulate early gene expression via A-to-I editing of dsRNAs," wrote R. Gu and colleagues, University of Connecticut.

The researchers concluded: "In this system, the defective polyadenylation, and consequently the production of multigenomic late RNAs, depends on the context, and perhaps also, on the A-to-I editing of the poly(A) signal that overlaps the 3'-end of early transcripts."

Gu and colleagues published the results of their research in RNA - a Publication of the RNA Society (Gene regulation by sense-antisense overlap of polyadenylation signals. RNA - a Publication of the RNA Society, 2009;15(6):1154-1163).

For additional information, contact G.G. Carmichael, University of Connecticut, Dept. of Genetics & Development Biology, Stem Cell Institute, Center Health, 263 Farmington Avenue, Farmington, CT 06030, USA.

The publisher of the journal RNA - a Publication of the RNA Society can be contacted at: Cold Spring Harbor Laboratory Press, Publications Dept., 500 Sunnyside Blvd., Woodbury, NY 11797-2924, USA.

Keywords: United States, Farmington, Antisense Technology, Biotechnology, DNA, DNA Replication, DNA Research, Gene Therapy, Genetics, Genomics, Medical Device, Polyomavirus, Treatment, Virology, University of Connecticut.

This article was prepared by Proteomics Weekly editors from staff and other reports. Copyright 2009, Proteomics Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login